Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biopharmaceutical company developing therapeutics using ...

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by Novo Nordisk and Eli Lilly — offering more coverage for Medicare and Medicaid ...

Conroe-based bio-tech company VGXI Inc. has defaulted on its tax abatement agreement with Montgomery County and will pay more ...

A University of Bristol spinout that has developed a supplement to support people with Irritable Bowel Syndrome (IBS) has reached a major milestone. The biotech company Ferryx, which launched its ...

Demy-Colton's BioFuturetm 2025 conference wrapped up in New York and virtually this week, sounding a positive tone for the biotech industry and the technologies and trends transforming the future of ...

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website IRVINE, Calif., Nov. 06, 2025 ...

THIRD QUARTER IN BRIEFActive Biotech provided status update for the development of laquinimod in inflammatory eye disorders and tasquinimod in hematological malignancies (July 8)Active Biotech present ...

Speculative activity surged across the micro-cap landscape during the third quarter, fueled by thematic momentum and outsized ...

Vancouver, Canada, November 4th, 2025, FinanceWire Equity Insider News Commentary – The precision medicine sector reached ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial ...

Synthetic biology is ready for the next developmental milestone and America’s leadership depends on getting the financing right.